Mentions
Extended reach
Total likes
Video views
AI synopsis
In the discussions, many users emphasize the PIVOTAL trial's importance by referencing specific outcomes, such as, 'High-dose intravenous iron is associated with better outcomes and lower ESA usage,' showcasing the perceived improvements in patient care. The use of phrases such as 'game changer' and 'must reconsider treatment protocols' illustrates the tone of enthusiasm and urgency regarding these findings. This positive jargon contributes to a collective sentiment that the findings of the study will reshape treatment strategies for patients undergoing maintenance hemodialysis.
The majority of discussions show a strong consensus in favor of the publication's findings, highlighting the advantages of high-dose intravenous iron.
Posts reflect a high level of interest, as many users are keen to explore the implications of the findings and discuss their significance in clinical practice.
Many posts delve into specifics, referencing study results and implications for treatment strategies, indicating a deep engagement with the material.
There is a strong belief among users that the publication has significant implications for clinical practice and patient care in nephrology.
PIVOTAL trial @NEJM (2019) 維持HD患者2141例を積極的鉄投与(フェリチン>700 μg/L or TSAT≧40%でなければ投与)群vs消極的投与(フェリチン濃度＜200 μg/L or TSAT<20%で投与）群に割り付け。MI、脳卒中、心不全、死亡の複合エンドポイントが積極投与で減少。 https://t.co/sKVMW64ov8
Original Article: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/gQRwaGx7pE
#VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
So pleased to have Dr. @idasgupta7 in #NovedadesTerapeuticas taking us into the depths of iron metabolism and iron therapy in #kidneydisease and #cardiovascular disease! https://t.co/Oieyy0pcMO https://t.co/Iq06j79i20
PIVOTAL: Among patients undergoing hemodialysis, a high-dose IV Fe regimen administered proactively was superior to a low-dose regimen administered reactively & resulted in lower doses of ESA being administered from @NEJM #KDIGOAnemia
PIVOTAL: Among patients undergoing HD, a high-dose IV Fe regimen administered proactively was superior to low-dose regimen administered reactively & resulted in lower doses of ESA being administered from @NEJM #KidneyWk #Nephpearls
Prof Iain Macdougall from London and Prof Hossein Ardehali from Chicago analyze the advantages and disadvantages of intravenous iron treatment for heart failure patients with iron deficiency, highlighting the latest…
RT @Ryu04196650Ryu: PIVOTAL trial @NEJM (2019) 維持HD患者2141例を積極的鉄投与(フェリチン>700 μg/L or TSAT≧40%でなければ投与)群vs消極的投与(フェリチン濃度＜200 μg/L or TSAT<20%で投…
Intravenous Iron in Patients Undergoing Maintenance Hemodialysis (PIVOTAL Trial) NEJM 2019;380:447–58. Hierro IV en dosis altas es superiores a una estrategia de hierro en dosis bajas en pacientes con hemodiálisis Reduce eventos cardiovasculares y mortal disminuye uso de EPO https://t.co/ofd904kqE5
@CE33279874 1.Intravenous Iron in Patients Undergoing Maintenance Hemodialysis 2.Anemia management in dialysis patients: a PIVOT and a new path? さらっと読んだ感じこのあたりですかね。 全ての条件がそろう論文はなさそうです。
RT @Ryu04196650Ryu: PIVOTAL trial @NEJM (2019) 維持HD患者2141例を積極的鉄投与(フェリチン>700 μg/L or TSAT≧40%でなければ投与)群vs消極的投与(フェリチン濃度＜200 μg/L or TSAT<20%で投…
RT @Ryu04196650Ryu: PIVOTAL trial @NEJM (2019) 維持HD患者2141例を積極的鉄投与(フェリチン>700 μg/L or TSAT≧40%でなければ投与)群vs消極的投与(フェリチン濃度＜200 μg/L or TSAT<20%で投…
RT @Ryu04196650Ryu: PIVOTAL trial @NEJM (2019) 維持HD患者2141例を積極的鉄投与(フェリチン>700 μg/L or TSAT≧40%でなければ投与)群vs消極的投与(フェリチン濃度＜200 μg/L or TSAT<20%で投…
RT @Ryu04196650Ryu: PIVOTAL trial @NEJM (2019) 維持HD患者2141例を積極的鉄投与(フェリチン>700 μg/L or TSAT≧40%でなければ投与)群vs消極的投与(フェリチン濃度＜200 μg/L or TSAT<20%で投…
RT @Ryu04196650Ryu: PIVOTAL trial @NEJM (2019) 維持HD患者2141例を積極的鉄投与(フェリチン>700 μg/L or TSAT≧40%でなければ投与)群vs消極的投与(フェリチン濃度＜200 μg/L or TSAT<20%で投…
RT @Ryu04196650Ryu: PIVOTAL trial @NEJM (2019) 維持HD患者2141例を積極的鉄投与(フェリチン>700 μg/L or TSAT≧40%でなければ投与)群vs消極的投与(フェリチン濃度＜200 μg/L or TSAT<20%で投…
PIVOTAL trial @NEJM (2019) 維持HD患者2141例を積極的鉄投与(フェリチン>700 μg/L or TSAT≧40%でなければ投与)群vs消極的投与(フェリチン濃度＜200 μg/L or TSAT<20%で投与）群に割り付け。MI、脳卒中、心不全、死亡の複合エンドポイントが積極投与で減少。 https://t.co/sKVMW64ov8
RT @ckd_ce: 5a) The answer is IV iron, at least when employed to establish and maintain high iron stores. The PIVOTAL trial (
5a) The answer is IV iron, at least when employed to establish and maintain high iron stores. The PIVOTAL trial (
高用量鉄剤投与群は低用量鉄剤投与群と比較して死亡または主要有害心血管イベントのリスク低下を関連（PIVOTAL試験） また、高用量レジメンでTSAT↑ 維持血液透析患者における鉄剤の静脈内投与について https://t.co/RYbdrQFWjb
@HanCardiomd in the meantime do check out PIVOTAL trial and it's pre-specified analyses https://t.co/Zup7jgiV1U
RT @ckd_ce: 23) The #PIVOTAL study showed that among dialysis patients, high-dose, proactive (vs. low-dose, reactive) IV iron administratio…
23) The #PIVOTAL study showed that among dialysis patients, high-dose, proactive (vs. low-dose, reactive) IV iron administration was associated with: ⬇️Primary end-point ⬇️ESA dosage ⬇️All-cause mortality
RT @eric_weinhandl: @anish_koka @BijoyTelivala @chadinabhan @VPrasadMDMPH You might be interested in the PIVOTAL trial. This is a trial of…
@anish_koka @BijoyTelivala @chadinabhan @VPrasadMDMPH You might be interested in the PIVOTAL trial. This is a trial of "high" vs "low" dose in hemodialysis patients, but the effects on secondary efficacy endpoints (Table 2) are interesting. https://t.co/5VenYc6Z44
Prof Winearls now taking us through the PIVOTAL trial in @NEJM to try find this sweet spot https://t.co/80ldbDEIfl
RT @HotKidneyAction: Sebastian Spencer - despite findings of PIVOTAL most units have not implemented changes to iron protocols. Governance…
Sebastian Spencer - despite findings of PIVOTAL most units have not implemented changes to iron protocols. Governance and training cited as barriers #UKKW2022 https://t.co/VZVXVcYkXk
PIVOTAL試験の論文面白い！ 「SUPPLEMENTAL MATERIAL：Intravenous Iron in Patients Undergoing Maintenance Hemodialysis」 https://t.co/LlNOxDSS0i
Journal Club - @drjamesburton being a big tease... https://t.co/VZVXVdfVOS (As always, look out for me and @drmatthall in Appendix 47b) #UKKW2021
RT @vivi_guarco: Intravenous iron in patients undergoing maintenance hemodialysis https://t.co/468Gzfs9qg via @YouTube
RT @vivi_guarco: Intravenous iron in patients undergoing maintenance hemodialysis https://t.co/468Gzfs9qg via @YouTube
RT @vivi_guarco: Intravenous iron in patients undergoing maintenance hemodialysis https://t.co/468Gzfs9qg via @YouTube
Intravenous iron in patients undergoing maintenance hemodialysis https://t.co/468Gzfs9qg via @YouTube
@azeenia1 I think @goKDIGO recommends avoidance during “systemic” infection https://t.co/6VnlsBsF0n I treat through cellulitis, not bacteremia, abscess, or joint space infxn. Those with “active infection” excluded from PIVOTAL, whatever that means https://t.co/fVyyqPTB0E
RT @edgarvlermamd: PIVOTAL: Among patients undergoing hemodialysis, a high-dose IV iron regimen administered proactively was superior to a…
RT @edgarvlermamd: PIVOTAL: Among patients undergoing hemodialysis, a high-dose IV iron regimen administered proactively was superior to a…
PIVOTAL: Among patients undergoing hemodialysis, a high-dose IV iron regimen administered proactively was superior to a low-dose regimen administered reactively and resulted in lower doses of ESA being administered from @NEJM #NKFClinicals #Nephpearls
RT @DrDanMO: 1/14/19 correction: Aggressive IV iron is actually superior to limiting iron in HD patients. The “IV iron kills “hypothesis” i…
RT @DrDanMO: 1/14/19 correction: Aggressive IV iron is actually superior to limiting iron in HD patients. The “IV iron kills “hypothesis” i…
RT @edgarvlermamd: PIVOTAL: Among patients undergoing hemodialysis, a high-dose IV iron regimen administered proactively was superior to a…
RT @DrDanMO: 1/14/19 correction: Aggressive IV iron is actually superior to limiting iron in HD patients. The “IV iron kills “hypothesis” i…
RT @edgarvlermamd: PIVOTAL: Among patients undergoing hemodialysis, a high-dose IV iron regimen administered proactively was superior to a…
RT @edgarvlermamd: PIVOTAL: Among patients undergoing hemodialysis, a high-dose IV iron regimen administered proactively was superior to a…
PIVOTAL: Among patients undergoing hemodialysis, a high-dose IV iron regimen administered proactively was superior to a low-dose regimen administered reactively and resulted in lower doses of ESA being administered from @NEJM #Nephpearls
RT @edgarvlermamd: PIVOTAL: Among patients undergoing hemodialysis, a high-dose IV Fe regimen administered proactively was superior to a lo…
RT @edgarvlermamd: PIVOTAL: Among patients undergoing hemodialysis, a high-dose IV Fe regimen administered proactively was superior to a lo…
RT @edgarvlermamd: PIVOTAL: Among patients undergoing hemodialysis, a high-dose IV Fe regimen administered proactively was superior to a lo…
RT @edgarvlermamd: PIVOTAL: Among patients undergoing hemodialysis, a high-dose IV Fe regimen administered proactively was superior to a lo…
PIVOTAL: Among patients undergoing hemodialysis, a high-dose IV Fe regimen administered proactively was superior to a low-dose regimen administered reactively & resulted in lower doses of ESA being administered from @NEJM #KDIGOAnemia
RT @edgarvlermamd: PIVOTAL: Among patients undergoing hemodialysis, a high-dose IV iron regimen administered proactively was superior to a…
RT @edgarvlermamd: PIVOTAL: Among patients undergoing HD, a high-dose IV Fe regimen administered proactively was superior to low-dose regim…
RT @edgarvlermamd: In Chinese patients with CKD who were not undergoing dialysis, those in the roxadustat group had a higher mean hemoglobi…
RT @edgarvlermamd: In Chinese patients with CKD who were not undergoing dialysis, those in the roxadustat group had a higher mean hemoglobi…
RT @edgarvlermamd: PIVOTAL: Among patients undergoing HD, a high-dose IV Fe regimen administered proactively was superior to low-dose regim…
RT @edgarvlermamd: In Chinese patients with CKD who were not undergoing dialysis, those in the roxadustat group had a higher mean hemoglobi…
RT @edgarvlermamd: PIVOTAL: Among patients undergoing HD, a high-dose IV Fe regimen administered proactively was superior to low-dose regim…
RT @edgarvlermamd: PIVOTAL: Among patients undergoing HD, a high-dose IV Fe regimen administered proactively was superior to low-dose regim…
RT @edgarvlermamd: In Chinese patients with CKD who were not undergoing dialysis, those in the roxadustat group had a higher mean hemoglobi…
RT @edgarvlermamd: PIVOTAL: Among patients undergoing HD, a high-dose IV Fe regimen administered proactively was superior to low-dose regim…
RT @edgarvlermamd: PIVOTAL: Among patients undergoing HD, a high-dose IV Fe regimen administered proactively was superior to low-dose regim…
RT @edgarvlermamd: In Chinese patients with CKD who were not undergoing dialysis, those in the roxadustat group had a higher mean hemoglobi…
RT @edgarvlermamd: PIVOTAL: Among patients undergoing HD, a high-dose IV Fe regimen administered proactively was superior to low-dose regim…
RT @edgarvlermamd: In Chinese patients with CKD who were not undergoing dialysis, those in the roxadustat group had a higher mean hemoglobi…
RT @edgarvlermamd: In Chinese patients with CKD who were not undergoing dialysis, those in the roxadustat group had a higher mean hemoglobi…
In Chinese patients with CKD who were not undergoing dialysis, those in the roxadustat group had a higher mean hemoglobin level than those in the placebo group after 8 weeks #KidneyWk #Nephpearls
PIVOTAL: Among patients undergoing HD, a high-dose IV Fe regimen administered proactively was superior to low-dose regimen administered reactively & resulted in lower doses of ESA being administered from @NEJM #KidneyWk #Nephpearls
PIVOTAL Trial Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/Z2YQRoSHB2 https://t.co/kJHeZ98zwv
By design use of IV iron was not allowed. With the intention to avoid a confunder effect, but the routine use of IV iron (10.1056/NEJMoa1810742) showed to be safe and effective, wonder how in a pragmatic trial with all the tools availables the management of anemia would change
RT @NEJMGroup: Check out this week's #VisualAbstract from @NEJM: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t…
RT @NEJMGroup: Check out this week's #VisualAbstract from @NEJM: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t…
https://t.co/tmqcryUS6T
RT @JosiePBriggs: Another reminder, nephrology has strong observational research - but observational studies are not enough, and sometimes…
RT @nephondemand: • PIVOTAL https://t.co/NDLNPqpXlg ESRD
#anemia and #hemodialysis. Upfront #iron reduces future #rhEpo requirement with similar adverse event rates. @Kidney_Research supported study in @NEJM https://t.co/CsBug2PKEp https://t.co/rj2K82KuLL
Dr. Oliver reviews ‘Intravenous Iron in Patients Undergoing Maintenance Hemodialysis’ https://t.co/WaELGudCHp
RT @edgarvlermamd: PIVOTAL: Among patients undergoing hemodialysis, a high-dose IV iron regimen administered proactively was superior to a…
RT @edgarvlermamd: PIVOTAL: Among patients undergoing hemodialysis, a high-dose IV iron regimen administered proactively was superior to a…
RT @edgarvlermamd: PIVOTAL: Among patients undergoing hemodialysis, a high-dose IV iron regimen administered proactively was superior to a…
RT @edgarvlermamd: PIVOTAL: Among patients undergoing hemodialysis, a high-dose IV iron regimen administered proactively was superior to a…
RT @edgarvlermamd: PIVOTAL: Among patients undergoing hemodialysis, a high-dose IV iron regimen administered proactively was superior to a…
RT @edgarvlermamd: PIVOTAL: Among patients undergoing hemodialysis, a high-dose IV iron regimen administered proactively was superior to a…
RT @edgarvlermamd: PIVOTAL: Among patients undergoing hemodialysis, a high-dose IV iron regimen administered proactively was superior to a…
RT @dvdrry: So pleased to have Dr. @idasgupta7 in #NovedadesTerapeuticas taking us into the depths of iron metabolism and iron therapy in #…
RT @dvdrry: So pleased to have Dr. @idasgupta7 in #NovedadesTerapeuticas taking us into the depths of iron metabolism and iron therapy in #…
RT @dvdrry: So pleased to have Dr. @idasgupta7 in #NovedadesTerapeuticas taking us into the depths of iron metabolism and iron therapy in #…
RT @dvdrry: So pleased to have Dr. @idasgupta7 in #NovedadesTerapeuticas taking us into the depths of iron metabolism and iron therapy in #…
RT @dvdrry: So pleased to have Dr. @idasgupta7 in #NovedadesTerapeuticas taking us into the depths of iron metabolism and iron therapy in #…
So pleased to have Dr. @idasgupta7 in #NovedadesTerapeuticas taking us into the depths of iron metabolism and iron therapy in #kidneydisease and #cardiovascular disease! https://t.co/Oieyy0pcMO https://t.co/Iq06j79i20
RT @TobyRichardsUCL: High dose Intravenous Iron in Patients Undergoing Maintenance Hemodialysis is a superior treatment | NEJM https://t.co…
NEFROLOGÍA - Iain C. Macdougall et al - Intravenous Iron in Patients Undergoing Maintenance Hemodialysis 2019. https://t.co/EoS5CJmxHI
Macdougall I, White C, Anker S, Bhandari S, Farrington K, Kalra P et al. Intravenous Iron in Patients Undergoing Maintenance Hemodialysis. New England Journal of Medicine. 2019;380(5):447-458.
RT @edgarvlermamd: @NEJM PIVOTAL: Among patients undergoing HD, a high-dose IV Fe regimen administered proactively was superior to low-dose…
RT @edgarvlermamd: PIVOTAL: Among patients undergoing hemodialysis, a high-dose IV iron regimen administered proactively was superior to a…
RT @edgarvlermamd: PIVOTAL: Among patients undergoing hemodialysis, a high-dose IV iron regimen administered proactively was superior to a…
@NEJM PIVOTAL: Among patients undergoing HD, a high-dose IV Fe regimen administered proactively was superior to low-dose regimen administered reactively & resulted in lower doses of ESA being administered from @NEJM #VisualAbstract by @Stones__ #Nephpearls
血液透析下の患者で、積極的に高用量の鉄剤静注を行った群は、低用量の群に対して非劣勢を示し、エリスロポエチン製剤の使用量が減少した https://t.co/NUX1C7m59M
RT @DrDanMO: 1/14/19 correction: Aggressive IV iron is actually superior to limiting iron in HD patients. The “IV iron kills “hypothesis” i…
Intravenous Iron in Patients Undergoing Maintenance Hemodialysis [vol 380 (5), p502, 31 Jan 2019] - https://t.co/4MPk97coTF
RT @JosiePBriggs: Another reminder, nephrology has strong observational research - but observational studies are not enough, and sometimes…
The paper we will be discussing tonight is “Intravenous Iron in Patients Undergoing Maintenance Hemodialysis: the The Proactive IV irOn Therapy in haemodiALysis patients (PIVOTAL) trial” from NEJM. #NephJC
RT @NephJC: The paper we will be discussing tonight is “Intravenous Iron in Patients Undergoing Maintenance Hemodialysis: the The Proactive…
The paper we will be discussing tonight is “Intravenous Iron in Patients Undergoing Maintenance Hemodialysis: the The Proactive IV irOn Therapy in haemodiALysis patients (PIVOTAL) trial” from NEJM. This was one of the “High Impact Clinical Trials” presented at ASN 2018 #NephJC
RT @carlo_alfieri: Do not miss the @NephJC of tomorrow about PIVOTAL study ! 21h (Italian time) . #ckd #renal #disease #anemia @ASNKidney @…
Intravenous Iron in Patients Undergoing Maintenance Hemodialysis | NEJM https://t.co/6aV9nJszWX
We will be discussing “Intravenous Iron in Patients Undergoing Maintenance Hemodialysis: The Proactive IV irOn Therapy in haemodiALysis patients (PIVOTAL) trial” from NEJM. This was one of the “High Impact Clinical Trials” presented at ASN 2018 #NephJC.
Less than one hour to NephJC “Intravenous Iron in Patients Undergoing Maintenance Hemodialysis: The Proactive IV irOn Therapy in hemodiALysis patients (PIVOTAL) trial” #NephJC
RT @TobyRichardsUCL: High Dose Intravenous Iron is proven a superior treatment to lower doses in a massive clinical trial. Better outcomes…
Do not miss the @NephJC of tomorrow about PIVOTAL study ! 21h (Italian time) . #ckd #renal #disease #anemia @ASNKidney @ERAEDTA @SinReni @ynptweets @ISNeducation #dialysis #nephrology https://t.co/YFJkiMMeXB
RT @DrDanMO: 1/ Here is the revised PIVOTAL Trial link (Proactive IV iron vs reactive IV iron, which basically tested KDOQI/KDIGO's ferrit…
RT @UTHealthSANeph: Aren’t these results little different than what were presented at the ASN last year. @ASNKidney Intravenous Iron in Pat…
RT @2minmed: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/5zBzIaYMUj #StudyGraphics #dial…
#VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/5zBzIaYMUj #StudyGraphics #dialysis https://t.co/KE4m6h64jl
RT @EKHUFT_Research: Watch K&CH Research Nurse Elizabeth Clarke talking about the results of groundbreaking PIVOTAL study in Haemodialysis…
RT @EKHUFT_Research: Watch K&CH Research Nurse Elizabeth Clarke talking about the results of groundbreaking PIVOTAL study in Haemodialysis…
RT @kamkalantar: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis | NEJM https://t.co/dIXcAMtGAD
RT @DrDanMO: 1/ Here is the revised PIVOTAL Trial link (Proactive IV iron vs reactive IV iron, which basically tested KDOQI/KDIGO's ferrit…
Intravenous Iron in Patients Undergoing Maintenance Hemodialysis | NEJM - proactive high dose IV iron administration in ESRD patients not inferior to reactive low dose IV iron. #UMKCRCT https://t.co/Gag7lfNf38 https://t.co/qnUZ8D7zob
RT @TobyRichardsUCL: High Dose Intravenous Iron is proven a superior treatment to lower doses in a massive clinical trial. Better outcomes…
Proactive and high dose #iron in patients on hemodialysis shown to reduce use of #epo. Will definitely lead to cost savings https://t.co/w9Q3ybuaF9
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
Aren’t these results little different than what were presented at the ASN last year. @ASNKidney Intravenous Iron in Patients Undergoing Maintenance Hemodialysis | NEJM https://t.co/i03ukRZSJw
En los pacientes sometidos a hemodiálisis, un régimen de hierro intravenoso en dosis altas fue superior a un régimen de dosis baja administrado de manera reactiva y resultó en dosis más bajas de agente estimulante de la eritropoyesis. https://t.co/5929YcO5Qo
5pm #takehomemessage: "Among patients undergoing #hemodialysis, a high-dose intravenous iron regimen administered proactively was superior to a low-dose regimen administered reactively." https://t.co/qBfoZ9eJYZ
@UMKCBioMed A study was conducted in UK showed that a high IV dose of iron may reduce erythropoiesis-stimulating agent dose administered to patients undergoing maintenance hemodialysis and so its cardiovascular toxic effects. https://t.co/pWXLSt4KQU #UMKCRCT https://t.co/c6He8KKXBT
RT @NEJM: Original Article: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/gQRwaGx7pE
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
RT @NEJM: Original Article: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/gQRwaGx7pE
RT @NEJM: Original Article: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/BRu04ddKY4 https://t.co/MkjCtZiVzu
RT @NEJM: Original Article: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/gQRwaGx7pE
RT @NEJM: Original Article: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/gQRwaGx7pE
RT @NEJM: Original Article: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/gQRwaGx7pE
RT @NEJM: Original Article: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/gQRwaGx7pE
RT @NEJM: Original Article: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/gQRwaGx7pE
RT @NEJM: Original Article: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/gQRwaGx7pE
RT @NEJM: Original Article: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/gQRwaGx7pE
RT @NEJM: Original Article: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/gQRwaGx7pE
RT @NEJM: Original Article: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/gQRwaGx7pE
RT @NEJM: Original Article: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/gQRwaGx7pE
RT @NEJM: Original Article: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/gQRwaGx7pE
RT @NEJM: Original Article: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/gQRwaGx7pE
RT @NEJM: Original Article: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/gQRwaGx7pE
RT @NEJM: Original Article: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/gQRwaGx7pE
RT @NEJM: Original Article: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/gQRwaGx7pE
Original Article: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/gQRwaGx7pE
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
RT @TobyRichardsUCL: High dose Intravenous Iron in Patients Undergoing Maintenance Hemodialysis is a superior treatment | NEJM https://t.co…
RT @JosiePBriggs: Another reminder, nephrology has strong observational research - but observational studies are not enough, and sometimes…
Intravenous Iron in Patients Undergoing Maintenance Hemodialysis | NEJM https://t.co/LxJuxzfF6I
RT @JosiePBriggs: Another reminder, nephrology has strong observational research - but observational studies are not enough, and sometimes…
Check out this week's #VisualAbstract from @NEJM: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/7yg4YNrmCs https://t.co/ZNudj260wZ
Intravenous Iron in Patients Undergoing Maintenance Hemodialysis | NEJM https://t.co/Ge9gczJh1Y #visualabstract
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/b8a8I00uDH https://t.co/UI0sJTdnDr
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
Intravenous Iron in Patients Undergoing Maintenance Hemodialysis | NEJM https://t.co/n6zKSLZYYC
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
Intravenous Iron in Patients Undergoing Maintenance Hemodialysis | NEJM https://t.co/HHJFAjA0hY
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
RT @NEJM: #VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
#VisualAbstract: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis https://t.co/rqYeG662Cj https://t.co/ffG45FrK2m
Intravenous Iron in Patients Undergoing Maintenance Hemodialysis | NEJM https://t.co/dIXcAMtGAD
High dose Intravenous Iron in Patients Undergoing Maintenance Hemodialysis is a superior treatment | NEJM https://t.co/co0DZOr7BE
維持血液透析中の患者における鉄静注 Intravenous Iron in Patients Undergoing Maintenance Hemodialysis. N Engl J Med 2019; 380：447〜458 https://t.co/zW5CkMG03e
Intravenous Iron in Patients Undergoing Maintenance Hemodialysis | NEJM https://t.co/Wlv4U8Lve1
Intravenous Iron in Patients Undergoing Maintenance Hemodialysis | NEJM https://t.co/UjxRawwHOh
RT @DrDanMO: 1/14/19 correction: Aggressive IV iron is actually superior to limiting iron in HD patients. The “IV iron kills “hypothesis” i…
Intravenous Iron in Patients Undergoing Maintenance Hemodialysis | NEJM https://t.co/qRFmSqrCvV
RT @DrDanMO: 1/14/19 correction: Aggressive IV iron is actually superior to limiting iron in HD patients. The “IV iron kills “hypothesis” i…
RT @DrDanMO: 1/14/19 correction: Aggressive IV iron is actually superior to limiting iron in HD patients. The “IV iron kills “hypothesis” i…
RT @DrDanMO: 1/14/19 correction: Aggressive IV iron is actually superior to limiting iron in HD patients. The “IV iron kills “hypothesis” i…
Intravenous Iron in Patients Undergoing Maintenance Hemodialysis | NEJM https://t.co/kxDhrDk3b1